Hologic, Inc. (HOLX) Tops Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Hologic (HOLX) PT, Estimates Raised at Jefferies Post Q2
May 1, 2014 9:46 AM EDTJefferies analyst Raj Denhoy lifted estimates and his price target on Buy-rated Hologic (NASDAQ: HOLX) to $26.00 (from $24.00) following solid Q2 results.
Denhoy commented, "HOLX put up a F2Q beat on strength in Tomo and... More
Hologic (HOLX) Buy Reiterated a Needham & Company Post Q2 on 'Encouraging' Return to Rev Growth
May 1, 2014 7:15 AM EDTNeedham & Company analyst Mike Matson reiterated a Buy rating and $26 price target on Hologic (NASDAQ: HOLX) following Q2 results which showed an 'encouraging' return to positive revenue growth.
Matson comments, "HOLX's F2Q14 results were well above consensus. Revenue upside was driven... More
